Le, T. Y. et al. (2026) “FIRST-LINE TREATMENT OUTCOMES OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: SINGLE-CENTER REAL-WORLD DATA FROM VIETNAM, FROM 2020 TO 2026”, Journal of Military Pharmaco-medicine, 51(8), pp. 152–161. doi: 10.56535/jmpm.v51i8.2085.